RPL17P40

Across TCGA pan-cancer cohorts, RPL17P40 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL17P40’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RPL17P40 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL17P40 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

UCEC, THCA, and COAD are the cancer types where RPL17P40 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL17P40 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	+0.450	.012	2	view →
THCA	All	All	−0.073	.005	2	view →
COAD	All	All	+0.067	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL17P40–UCEC

Open the UCEC breakdown →